MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
CRSP
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

CRISPR Therapeutics AG (CRSP) Earnings Date & Reports

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

CRSP is expected to report earnings to fall 10.22% to -123 cents per share on May 11

CRISPR Therapeutics AG CRSP Stock Earnings Reports
Q1'26
Est.
$-1.23
Q4'25
Missed
by $0.20
Q3'25
Beat
by $0.09
Q2'25
Missed
by $1.00
Q1'25
Missed
by $0.37
The last earnings report on February 12 showed earnings per share of -137 cents, missing the estimate of -116 cents. With 439.48K shares outstanding, the current market capitalization sits at 5.33B.
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
CRSP
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. CRSP showed earnings on February 12, 2026. You can read more about the earnings report here.
View AI-Driven Trading for CRSP
A.I. Advisor
published General Information

General Information

a developer of gene-based medicines

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
Baarerstrasse 14
Phone
+41 415613277
Employees
407
Web
https://www.crisprtx.com